Conclusion
We have described the treatment of children with IH with propranolol
only or initial propranolol therapy followed by laser therapy, surgical
excision, corticosteroid therapy, or a second cycle of propranolol at a
tertiary medical center. The study confirms propranolol’s effectiveness
and safety, reinforcing the need for early intervention and close
monitoring following treatment termination to prevent regrowth. The
results highlight the value of proactively addressing IH in this
population and underscore the potential impact of familial history on
treatment outcomes. The pursuit of larger prospective, multicenter
studies encompassing diverse IH cases is warranted to fortify these
findings. Ultimately, this research contributes to advancing the
understanding and treatment of IH, aiming to optimize patient outcomes
and reduce morbidity.